Literature DB >> 21737612

mRNA expression of the putative antimetastatic gene BRMS1 and of apoptosis-related genes in breast cancer.

J Schneider1, F Gómez-Esquer, G Díaz-Gil, R Torrejón, M Pollán.   

Abstract

Breast cancer metastasis suppressor-1 (BRMS1) is a putative antimetastatic gene. However, results relating its expression to the prognosis of breast cancer are still controversial, and all studies carried out to date have failed to show a relationship between the expression of BRMS1 and axillary lymph node metastasis in breast cancer. It has been recently suggested that BRMS1 may exert its physiological role through the modulation of apoptosis. In order to test this hypothesis, we studied the expression of BRMS1 and genes known to be directly related with apoptosis in human breast carcinoma. The expression of mRNA corresponding to BRMS1, BCL2, BAX, CASP3 and the apoptosis-related X-chromosome RNA binding motif (RBM) genes (RBMX, RBM3, RBM10 small and large variant) was studied by means of differential RT-PCR in 94 samples obtained from previously untreated patients with breast carcinoma. A significant (p=0.03) inverse correlation between BRMS1 mRNA expression and expression of the mRNA corresponding to the large variant of the X-chromosome RBM10 gene was found. The degree of direct correlation with another member of the X-chromosome RBM gene family, RBMX, almost attained statistical significance (p=0.06). These results point towards a possible link between BRMS1 expression and apoptosis in human breast cancer through a relationship with the expression of genes belonging to the X-chromosome RBM family.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21737612

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  5 in total

1.  Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis.

Authors:  Leah M Cook; Xuemei Cao; Alexander E Dowell; Michael T Debies; Mick D Edmonds; Benjamin H Beck; Robert A Kesterson; Renee A Desmond; Andra R Frost; Douglas R Hurst; Danny R Welch
Journal:  Clin Exp Metastasis       Date:  2012-01-13       Impact factor: 5.150

2.  Breast cancer metastasis suppressor-1 promoter methylation in primary breast tumors and corresponding circulating tumor cells.

Authors:  Maria Chimonidou; Galatea Kallergi; Vassilis Georgoulias; Danny R Welch; Evi S Lianidou
Journal:  Mol Cancer Res       Date:  2013-06-06       Impact factor: 5.852

3.  Integrated Bioinformatics Analysis and Validation of the Prognostic Value of RBM10 Expression in Hepatocellular Carcinoma.

Authors:  Shu-Jie Pang; Zhe Sun; Wen-Feng Lu; Hui Si-Ma; Zhi-Peng Lin; Yang Shi; Ying-Cheng Yang; Xi-Jun Zhao; Guang-Shun Yang; Guang-Zhi Jin; Ning Yang
Journal:  Cancer Manag Res       Date:  2022-03-04       Impact factor: 3.989

4.  OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes.

Authors:  Rocco Piazza; Daniele Ramazzotti; Roberta Spinelli; Alessandra Pirola; Luca De Sano; Pierangelo Ferrari; Vera Magistroni; Nicoletta Cordani; Nitesh Sharma; Carlo Gambacorti-Passerini
Journal:  Sci Rep       Date:  2017-04-07       Impact factor: 4.379

5.  Cullin3 promotes breast cancer cells metastasis and epithelial-mesenchymal transition by targeting BRMS1 for degradation.

Authors:  Xiongwei Huo; Suoni Li; Tingting Shi; Aili Suo; Zhiping Ruan; Hui Guo; Yu Yao
Journal:  Oncotarget       Date:  2015-12-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.